C
Chiome Bioscience Inc
TSE:4583
Chiome Bioscience Inc
TSE:4583
Price:
123 JPY
-2.38%
Updated:
May 6, 2024
Chiome Bioscience Inc
Cash from Operating Activities
|
Chiome Bioscience Inc
Cash from Operating Activities Peer Comparison
Comparables:
2309
2370
4880
2183
7079
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
C
|
Chiome Bioscience Inc
TSE:4583
|
Cash from Operating Activities
-¥1.1B
|
CAGR 3-Years
8%
|
CAGR 5-Years
9%
|
CAGR 10-Years
-9%
|
|
|
CMIC Holdings Co Ltd
TSE:2309
|
Cash from Operating Activities
¥6.7B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
3%
|
|
|
Medinet Co Ltd
TSE:2370
|
Cash from Operating Activities
-¥1.3B
|
CAGR 3-Years
-26%
|
CAGR 5-Years
13%
|
CAGR 10-Years
-9%
|
|
|
CellSource Co Ltd
TSE:4880
|
Cash from Operating Activities
¥846.7m
|
CAGR 3-Years
37%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
|
Linical Co Ltd
TSE:2183
|
Cash from Operating Activities
¥1.8B
|
CAGR 3-Years
143%
|
CAGR 5-Years
29%
|
CAGR 10-Years
25%
|
|
|
WDB coco Co Ltd
TSE:7079
|
Cash from Operating Activities
¥517.5m
|
CAGR 3-Years
12%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
See Also
What is Chiome Bioscience Inc's Cash from Operating Activities?
Cash from Operating Activities
-1.1B
JPY
-1.1B
JPY
Based on the financial report for Dec 31, 2023, Chiome Bioscience Inc's Cash from Operating Activities amounts to -1.1B JPY.
What is Chiome Bioscience Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-9%
-9%
Over the last year, the Cash from Operating Activities growth was 10%. The average annual Cash from Operating Activities growth rates for Chiome Bioscience Inc have been 8% over the past three years , 9% over the past five years , and -9% over the past ten years .
You don't have any saved screeners yet
